Second, diverse mutations of FUNDC2 including S167L, C96Y, and M139I are found in different cancer patients (Fig 6), as evidenced in the TCGA databases, suggesting that these variations of FUNDC2 at least are supported by clinical data. The gene discussed is FUNDC2; the disease is cancer.